Opening book details…
About this book
Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis by Joseph Carpenter, Gang Wu, Ying Wang, Erica M. Cook, Tao Wang, Doree Sitkoff, Karen A. Rossi, Kathy Mosure, Xiaoliang Zhuo, Gary G. Cao, Milinda Ziegler, Anthony V. Azzara, Jack Krupinski, Matthew G. Soars, Bruce Alan Ellsworth & Dean A. Wacker is a book available to read on EtoBox.
- Author
- Joseph Carpenter, Gang Wu, Ying Wang, Erica M. Cook, Tao Wang, Doree Sitkoff, Karen A. Rossi, Kathy Mosure, Xiaoliang Zhuo, Gary G. Cao, Milinda Ziegler, Anthony V. Azzara, Jack Krupinski, Matthew G. Soars, Bruce Alan Ellsworth & Dean A. Wacker
- Published
- 2021
- Language
- EN
More by Joseph Carpenter, Gang Wu, Ying Wang, Erica M. Cook, Tao Wang, Doree Sitkoff, Karen A. Rossi, Kathy Mosure, Xiaoliang Zhuo, Gary G. Cao, Milinda Ziegler, Anthony V. Azzara, Jack Krupinski, Matthew G. Soars, Bruce Alan Ellsworth & Dean A. Wacker
Similar books
- Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2 — Michael G. Yang, Zili Xiao, Rulin Zhao, Andrew J. Tebben, Bei Wang, Robert J. Cherney, Douglas G. Batt, Gregory D. Brown, Mary Ellen Cvijic, John V. Duncia, Michael A. Gallela, Daniel S. Gardner, Purnima Khandelwal, Mary F. Malley, Jian Pang, Anne V.... (2021)
- A New FXR Ligand Chemotype with Agonist/Antagonist Switch — Moritz Helmstädter, Jan Vietor, Jana Sommer, Simone Schierle, Sabine Willems, Astrid Kaiser, Jurema Schmidt & Daniel Merk (2021)
- Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1 — Emily C. Cherney, Liping Zhang, Susheel Nara, Xiao Zhu, Johnni Gullo-Brown, Derrick Maley, Tai-An Lin, John T. Hunt, Christine Huang, Zheng Yang, Celia Darienzo, Lorell Discenza, Asoka Ranasinghe, Mary Grubb, Theresa Ziemba, Sarah C. Traeger, Xin Li,... (2021)
- BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate — Robert J. Cherney, Prakash Anjanappa, Kumaravel Selvakumar, Douglas G. Batt, Gregory D. Brown, Anne V. Rose, Ragini Vuppugalla, Jing Chen, Jian Pang, Songmei Xu, Melissa Yarde, Andrew J. Tebben, Venkatram Reddy Paidi, Mary Ellen Cvijic, Arvind Mathur,... (2021)
- Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia — Michele L. R. Heffernan, Lee W. Herman, Scott Brown, Philip G. Jones, Liming Shao, Michael C. Hewitt, John E. Campbell, Nina Dedic, Seth C. Hopkins, Kenneth S. Koblan & Linghong Xie (2022)
- Discovery of a Potent and Selective Covalent p300/CBP Inhibitor — Anthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, Damien B. Ready, Loren M. Lasko, Kenneth D. Bromberg, William J. McClellan, Debra Montgomery, Vlasios Manaves, Bailin Shaw, Mikkel Algire, Melanie J. Patterson, Chaohong C. Sun, Saul Rosenberg,... (2021)